Piraeus Bank S.A. Greece
⚠️ Moderate Risk
FEI: 3006554578 • Athens, Athina • GREECE
FEI Number
3006554578
Location
Athens, Athina
Country
GREECEAddress
Amerikis 4, , Athens, Athina, Greece
Moderate Risk
FDA Import Risk Assessment
This firm has a moderate history of FDA import refusals. Some attention may be warranted.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
NOT LISTED
It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 12/11/2007 | 56JCY22CLINDAMYCIN PHOSPHATE (LINCOMYCINS) | New York District Office (NYK-DO) | |
| 12/11/2007 | 61WCY44ECONAZOLE NITRATE (ANTI-FUNGAL) (NOT ANTIBIOTIC) | New York District Office (NYK-DO) | |
| 12/11/2007 | 61WDA45FLUCONAZOLE (ANTI-FUNGAL) (NOT ANTIBIOTIC) | New York District Office (NYK-DO) |
Frequently Asked Questions
What is Piraeus Bank S.A. Greece's FDA import refusal history?
Piraeus Bank S.A. Greece (FEI: 3006554578) has 3 FDA import refusal record(s) in our database, spanning from 12/11/2007 to 12/11/2007.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Piraeus Bank S.A. Greece's FEI number is 3006554578.
What types of violations has Piraeus Bank S.A. Greece received?
Piraeus Bank S.A. Greece has been cited for 2 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Piraeus Bank S.A. Greece come from?
All FDA import refusal data for Piraeus Bank S.A. Greece is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.